Exhibit 107
Calculation of Filing Fee Tables
Form
S-1
(Form Type)
Ensysce
Biosciences, Inc.
(Exact Name of Each Registrant as Specified in its Charter)
Table 1: Newly Registered and Carry Forward Securities
Security Type | Security Class Title | Fee Calculation or Carry Forward Rule | Amount Registered | Proposed Maximum Offering Price Per Unit | Maximum Aggregate Offering Price(1) | Fee Rate(2) | Amount of Registration Fee (2) | Carry Forward Form Type | Carry Forward File Number | Carry Forward Initial effective date | Filing Fee Previously Paid In Connection with Unsold Securities to be Carried Forward | |||||||||||||||||||||||||||||||||
Newly Registered Securities | ||||||||||||||||||||||||||||||||||||||||||||
Fees to Be Paid | Equity | Common Stock, par value $0.0001 per share (“Common Stock”)(3)(4) | 457 | (o) | $ | 8,000,000.00 | $ | 881.60 | ||||||||||||||||||||||||||||||||||||
Other | Pre-funded Warrants to purchase Common Stock(4) | 457 | (g) | (included above) | ||||||||||||||||||||||||||||||||||||||||
Equity | Common Stock underlying the Pre-funded Warrants to purchase Common Stock(3)(4) | 457 | (o) | (4 | ) | (4 | ) | |||||||||||||||||||||||||||||||||||||
Other | Series A-1 Warrants to purchase Common Stock | 457 | (g) | - | (5 | ) | ||||||||||||||||||||||||||||||||||||||
Equity | Common Stock underlying the Series A-1 Warrants to purchase Common Stock(3) | 457 | (o) | $ | 8,000,000.00 | $ | 881.60 | |||||||||||||||||||||||||||||||||||||
Other | Series A-2 Warrants to purchase Common Stock | 457 | (g) | - | (5 | ) | ||||||||||||||||||||||||||||||||||||||
Equity | Common Stock underlying Series A-2 Warrants to purchase Common Stock(3) | 457 | (o) | $ | 8,000,000.00 | $ | 881.60 | |||||||||||||||||||||||||||||||||||||
Other | Placement Agent Warrants to purchase Common Stock | 457 | (g) | - | (5 | ) | ||||||||||||||||||||||||||||||||||||||
Equity | Common Stock underlying Placement Agent Warrants to purchase Common Stock(3) | 457 | (o) | $ | 700,000.00 | $ | 78.00 | |||||||||||||||||||||||||||||||||||||
Fees Previously Paid | $ | 2,644.80 | ||||||||||||||||||||||||||||||||||||||||||
Carry Forward Securities | ||||||||||||||||||||||||||||||||||||||||||||
Carry Forward Securities | ||||||||||||||||||||||||||||||||||||||||||||
Total Offering Amounts | $ | 24,700,000.00 | $ | 2,722.80 | ||||||||||||||||||||||||||||||||||||||||
Total Fees Previously Paid | 2,644.80 | |||||||||||||||||||||||||||||||||||||||||||
Total Fee Offsets | - | |||||||||||||||||||||||||||||||||||||||||||
Net Fee Due | $ | 78 |
(1) | Estimated solely for the purpose of calculating the amount of the registration fee in pursuant to Rule 457(o) under the Securities Act of 1933, as amended (the “Securities Act”) |
(2) | The registration fee is calculated in accordance with Rule 457(o) under the Securities Act at a fee rate of 0.00011020 ($110.20 per $1 million). |
(3) | Pursuant to Rule 416 under the Securities Act, this registration statement shall also cover any additional shares of the registrant’s securities that become issuable by reason of any share splits, share dividends or similar transactions. |
(4) | The proposed maximum aggregate offering price of the Common Stock will be reduced on a dollar-for-dollar basis based on the offering price of any pre-funded warrants issued in the offering, and the proposed maximum aggregate offering price of the pre-funded warrants to be issued in the offering will be reduced on a dollar-for-dollar basis based on the offering price of any Common Stock issued in the offering and Common Stock issuable upon exercise of Series A-1 Warrants and Series A-2 Warrants. Accordingly, the proposed maximum aggregate offering price of the Common Stock and pre-funded warrants (including the Common Stock issuable upon exercise of the pre-funded warrants), if any, is $8,000,000. |
(5) | No separate registration fee is payable pursuant to Rule 457(g) under the Securities Act for the warrants because the warrants are being registered in the same registration statement as the common stock issuable upon exercise of the warrants. |